<p>，/PRNewswire/ -- Azra AI 是一家医疗企业平台，通过先进的人工智能和自动化技术，正在转变癌症护理协调和临床路径的编排，今天宣布任命 Jessica Turgon 为其董事会成员。</p>
<p>Turgon 是一位全国公认的肿瘤战略家和医疗高管，拥有数十年的经验，曾为领先的医疗系统、癌症中心和医疗组织提供有关肿瘤增长、运营转型和护理交付创新的咨询。她曾担任西门子医疗的全球肿瘤服务线负责人，并在 ECG 管理顾问公司工作了 20 年，领导全国范围内的肿瘤咨询项目。</p>
<p>她的任命正值医疗系统日益寻求可扩展的人工智能驱动解决方案，以改善癌症筛查、护理协调、运营效率和患者结果，同时应对日益增长的临床和人力资源压力。</p>
<p>“Jessica 在医疗保健的关键时刻带来了卓越的肿瘤专业知识、医疗系统战略和运营洞察，” Azra AI 的首席执行官 John Marshall 表示。“她在帮助医疗系统应对复杂性和建立更强大的肿瘤项目以改善患者护理方面度过了她的职业生涯。随着 Azra 在肿瘤运营中继续扩大人工智能的应用，Jessica 的视角和领导力将对我们加速使命和扩大影响力至关重要。”</p>
<p>在她的职业生涯中，Turgon 曾为医疗组织提供有关癌症服务线战略、患者获取、护理交付优化、医生对齐和企业转型项目的咨询。她因对肿瘤项目面临的运营和临床挑战的深刻理解而广受认可，并帮助组织现代化护理模式，以更好地服务患者。</p>
<p>在西门子医疗，Turgon 领导全球肿瘤战略工作，专注于推进综合癌症护理和通过创新及技术驱动的转型改善结果。在 ECG 任职期间，她因帮助医院和医疗系统加强肿瘤运营而闻名，同时始终关注患者体验。</p>
<p>“Azra AI 正在解决当今医疗保健中最重要的挑战之一：帮助医疗系统将分散的数据转化为协调的、可操作的护理，形成一个完整的端到端平台。” Turgon 说。“该公司将人工智能操作化的能力直接支持肿瘤团队，加速患者识别和治疗，并改善护理连续性，令人信服。我很高兴能加入董事会，支持 Azra 的持续增长和使命。”</p>
<p>Azra AI 的企业平台将未充分利用的医疗数据操作化，以优化和编排护理和临床试验路径——确保患者在其医疗系统内获得及时、协调的护理，提高患者保留率和结果，并通过可操作的实时报告使患者护理可见。</p>
<p>通过结合先进的代理人工智能、多模态数据集成和工作流程自动化，Azra 将分散的临床数据转化为可操作的智能——为肺癌和乳腺癌筛查、偶发发现、多学科会议、企业患者管理和护理协调、研究和临床试验匹配、急诊出院工作流程以及高级报告和分析提供解决方案。</p>
<p>该平台在单一生态系统内统一这些能力，使医疗系统能够更早识别患者，纵向协调护理，并消除整个连续性中的空白。Azra AI 在数百个领先的医疗系统中部署，帮助减少治疗时间，同时推动患者结果、运营效率和规模化投资回报的可衡量改善。</p>
<p><strong>关于 Azra AI</strong></p>
<p>Azra AI 是一家医疗企业平台，将未充分利用的数据操作化，以优化和编排护理和临床试验路径——确保患者在其医疗系统内获得及时、协调的护理，提高患者保留率和结果，并通过可操作的实时报告使患者护理可见。</p>
<p>通过结合先进的代理人工智能、多模态数据集成和工作流程自动化，Azra 将分散的临床数据转化为可操作的智能——为肺癌和乳腺癌筛查、所有偶发发现、多学科会议、企业患者管理/护理协调、研究/临床试验匹配、急诊出院和强大的报告与分析提供解决方案。</p>
<p>Azra 在单一平台内统一这些能力，使医疗系统能够更早识别患者，纵向协调护理，并消除整个连续性中的空白。Azra 的平台在数百个领先的医疗系统中部署，减少治疗时间，从而在患者结果、运营效率和规模化投资回报方面带来可衡量的改善。</p>
<p>了解更多信息，请访问 www.azra-ai.com。</p>
<p>媒体联系人：</p>
<p>John Marshall</p>
<p>[email protected]</p>
<p>来源：Azra AI</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE5Jk5ld3NJdGVtSWQ9Q0w2MjExNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTkwOTAzUFJfTkVXU19VU1BSX19fX19DTDYyMTE3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE5Jk5ld3NJdGVtSWQ9Q0w2MjExNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTkwOTAzUFJfTkVXU19VU1BSX19fX19DTDYyMTE3"/></p>

<p>Azra AI 已任命公认的肿瘤战略家杰西卡·图尔贡（Jessica Turgon）为其董事会成员。图尔贡在肿瘤增长和运营转型方面拥有丰富的经验，曾在西门子医疗（Siemens Healthineers）和 ECG 管理顾问公司工作。她的专业知识将支持 Azra AI 的使命，通过人工智能驱动的解决方案提升癌症护理协调，解决当今医疗保健中的关键挑战</p>

<p>, /PRNewswire/ -- Azra AI, the healthcare enterprise platform transforming cancer care coordination and clinical pathway orchestration through advanced AI and automation, today announced the appointment of Jessica Turgon to its Board of Directors.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Azra AI 是一家医疗企业平台，通过先进的人工智能和自动化技术，正在转变癌症护理协调和临床路径的编排，今天宣布任命 Jessica Turgon 为其董事会成员。</p>
</div><p>Turgon is a nationally recognized oncology strategist and healthcare executive with decades of experience advising leading health systems, cancer centers, and healthcare organizations on oncology growth, operational transformation, and care delivery innovation. She has previously worked roles as Global Service Line Head for Oncology a Siemens Healthineers and spent 20 years at ECG Management Consultants, where she led oncology consulting initiatives for health systems across the country.</p>
<div class="lb-trans"><p>Turgon 是一位全国公认的肿瘤战略家和医疗高管，拥有数十年的经验，曾为领先的医疗系统、癌症中心和医疗组织提供有关肿瘤增长、运营转型和护理交付创新的咨询。她曾担任西门子医疗的全球肿瘤服务线负责人，并在 ECG 管理顾问公司工作了 20 年，领导全国范围内的肿瘤咨询项目。</p>
</div><p>Her appointment comes as health systems increasingly seek scalable AI-driven solutions to improve cancer screening, care coordination, operational efficiency, and patient outcomes amid growing clinical and workforce pressures.</p>
<div class="lb-trans"><p>她的任命正值医疗系统日益寻求可扩展的人工智能驱动解决方案，以改善癌症筛查、护理协调、运营效率和患者结果，同时应对日益增长的临床和人力资源压力。</p>
</div><p>&#34;Jessica brings an extraordinary combination of oncology expertise, health system strategy, and operational insight at a pivotal moment for healthcare,&#34; said John Marshall, CEO of Azra AI. &#34;She has spent her career helping health systems navigate complexity and build stronger oncology programs that improve patient care. As Azra continues scaling AI adoption across oncology operations, Jessica's perspective and leadership will be invaluable in helping us accelerate our mission and expand our impact.&#34;</p>
<div class="lb-trans"><p>“Jessica 在医疗保健的关键时刻带来了卓越的肿瘤专业知识、医疗系统战略和运营洞察，” Azra AI 的首席执行官 John Marshall 表示。“她在帮助医疗系统应对复杂性和建立更强大的肿瘤项目以改善患者护理方面度过了她的职业生涯。随着 Azra 在肿瘤运营中继续扩大人工智能的应用，Jessica 的视角和领导力将对我们加速使命和扩大影响力至关重要。”</p>
</div><p>Throughout her career, Turgon has advised healthcare organizations on cancer service line strategy, patient access, care delivery optimization, physician alignment, and enterprise transformation initiatives. She is widely recognized for her deep understanding of the operational and clinical challenges facing oncology programs and for helping organizations modernize care models to better serve patients.</p>
<div class="lb-trans"><p>在她的职业生涯中，Turgon 曾为医疗组织提供有关癌症服务线战略、患者获取、护理交付优化、医生对齐和企业转型项目的咨询。她因对肿瘤项目面临的运营和临床挑战的深刻理解而广受认可，并帮助组织现代化护理模式，以更好地服务患者。</p>
</div><p>At Siemens Healthineers, Turgon lead global oncology strategy efforts focused on advancing integrated cancer care and improving outcomes through innovation and technology-enabled transformation. During her tenure at ECG, she became known for her work helping hospitals and health systems strengthen oncology operations while maintaining a strong focus on the patient experience.</p>
<div class="lb-trans"><p>在西门子医疗，Turgon 领导全球肿瘤战略工作，专注于推进综合癌症护理和通过创新及技术驱动的转型改善结果。在 ECG 任职期间，她因帮助医院和医疗系统加强肿瘤运营而闻名，同时始终关注患者体验。</p>
</div><p>&#34;Azra AI is addressing one of the most important challenges in healthcare today: helping health systems turn fragmented data into coordinated, actionable care in a single end-to-end platform.&#34; said Turgon. &#34;The company's ability to operationalize AI in a way that directly supports oncology teams, accelerates patient identification and treatment, and improves continuity of care is incredibly compelling. I'm excited to join the Board and support Azra's continued growth and mission.&#34;</p>
<div class="lb-trans"><p>“Azra AI 正在解决当今医疗保健中最重要的挑战之一：帮助医疗系统将分散的数据转化为协调的、可操作的护理，形成一个完整的端到端平台。” Turgon 说。“该公司将人工智能操作化的能力直接支持肿瘤团队，加速患者识别和治疗，并改善护理连续性，令人信服。我很高兴能加入董事会，支持 Azra 的持续增长和使命。”</p>
</div><p>Azra AI's enterprise platform operationalizes underutilized healthcare data to optimize and orchestrate care and clinical trial pathways — ensuring patients receive immediate, coordinated care within their health system, increasing patient retention and outcomes, and making patient care visible through actionable real-time reporting.</p>
<div class="lb-trans"><p>Azra AI 的企业平台将未充分利用的医疗数据操作化，以优化和编排护理和临床试验路径——确保患者在其医疗系统内获得及时、协调的护理，提高患者保留率和结果，并通过可操作的实时报告使患者护理可见。</p>
</div><p>By combining advanced agentic AI, multimodal data integration, and workflow automation, Azra transforms fragmented clinical data into actionable intelligence — powering solutions across lung and breast cancer screening, incidental findings, multidisciplinary meetings, enterprise patient management and care coordination, research and clinical trial matching, ED discharge workflows, and advanced reporting and analytics.</p>
<div class="lb-trans"><p>通过结合先进的代理人工智能、多模态数据集成和工作流程自动化，Azra 将分散的临床数据转化为可操作的智能——为肺癌和乳腺癌筛查、偶发发现、多学科会议、企业患者管理和护理协调、研究和临床试验匹配、急诊出院工作流程以及高级报告和分析提供解决方案。</p>
</div><p>The platform's ability to unify these capabilities within a single ecosystem enables health systems to identify patients earlier, coordinate care longitudinally, and eliminate gaps across the continuum. Deployed across hundreds of leading health systems, Azra AI helps reduce time to treatment while driving measurable improvements in patient outcomes, operational efficiency, and ROI at scale.</p>
<div class="lb-trans"><p>该平台在单一生态系统内统一这些能力，使医疗系统能够更早识别患者，纵向协调护理，并消除整个连续性中的空白。Azra AI 在数百个领先的医疗系统中部署，帮助减少治疗时间，同时推动患者结果、运营效率和规模化投资回报的可衡量改善。</p>
</div><p><strong>About Azra AI</strong></p>
<div class="lb-trans"><p><strong>关于 Azra AI</strong></p>
</div><p>Azra AI is a healthcare enterprise platform that operationalizes underutilized data to optimize and orchestrate care and clinical trial pathways — ensuring patients receive immediate, coordinated care within their health system, increasing patient retention and outcomes, and making patient care visible through actionable real-time reporting.</p>
<div class="lb-trans"><p>Azra AI 是一家医疗企业平台，将未充分利用的数据操作化，以优化和编排护理和临床试验路径——确保患者在其医疗系统内获得及时、协调的护理，提高患者保留率和结果，并通过可操作的实时报告使患者护理可见。</p>
</div><p>By combining advanced agentic AI, multimodal data integration, and workflow automation, Azra transforms fragmented clinical data into actionable intelligence—powering solutions across lung and breast cancer screening, all incidental findings, multi-disciplinary meetings, enterprise patient management / care coordination, research / clinical trial matching, ED discharge, and robust reporting and analytics.</p>
<div class="lb-trans"><p>通过结合先进的代理人工智能、多模态数据集成和工作流程自动化，Azra 将分散的临床数据转化为可操作的智能——为肺癌和乳腺癌筛查、所有偶发发现、多学科会议、企业患者管理/护理协调、研究/临床试验匹配、急诊出院和强大的报告与分析提供解决方案。</p>
</div><p>Azra's ability to unify these capabilities within a single platform enables health systems to identify patients earlier, coordinate care longitudinally, and eliminate gaps across the continuum. Deployed across hundreds of leading health systems, Azra's platform reduces time to treatment, which delivers measurable improvements in patient outcomes, operational efficiency, and ROI at scale.</p>
<div class="lb-trans"><p>Azra 在单一平台内统一这些能力，使医疗系统能够更早识别患者，纵向协调护理，并消除整个连续性中的空白。Azra 的平台在数百个领先的医疗系统中部署，减少治疗时间，从而在患者结果、运营效率和规模化投资回报方面带来可衡量的改善。</p>
</div><p>Learn more at www.azra-ai.com.</p>
<div class="lb-trans"><p>了解更多信息，请访问 www.azra-ai.com。</p>
</div><p>Media Contact:</p>
<div class="lb-trans"><p>媒体联系人：</p>
</div><p>John Marshall</p>
<div class="lb-trans"><p>John Marshall</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE Azra AI</p>
<div class="lb-trans"><p>来源：Azra AI</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE5Jk5ld3NJdGVtSWQ9Q0w2MjExNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTkwOTAzUFJfTkVXU19VU1BSX19fX19DTDYyMTE3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CL62117&amp;Transmission_Id=202605190903PR_NEWS_USPR_____CL62117&amp;DateId=20260519"/></p>

Azra AI 任命肿瘤学领域的领导者 Jessica Turgon 加入董事会